Organizations
Conferences
Info & Opinion
March 14, 2010
PHT chief says the current growth may not dampen for years: “They’re not coming forward with one or two studies. They show up with five studies over a 2-year period.”
Business at PHT is brisk. The private company doesn’t release financial data, but did issue a press release about its recent quarter. Its solution was selected by 10 biopharmaceutical companies for use in a record 26 new studies worldwide. The company,…
No articles available